Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
78.59
-1.35 (-1.69%)
At close: Oct 16, 2026, 4:00 PM EDT
78.54
-0.05 (-0.06%)
After-hours: Oct 16, 2026, 7:30 PM EDT
KNSA Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, KNSA stock has a consensus rating of "Strong Buy" and an average price target of $98. The average 1-year stock price forecast is 24.70% higher than the current stock price, while the lowest is $87 (+10.70%) and the highest is $108 (+37.42%).
Price Target: $98 (+24.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $100 | Buy | Maintains | $100 | +27.24% | Oct 15, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $87 | Buy | Maintains | $87 | +10.70% | Sep 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $98 | Buy | Reiterates | $98 | +24.70% | Aug 13, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $75 → $90 | Buy | Maintains | $75 → $90 | +14.52% | Jul 30, 2026 |
| Wedbush | Wedbush | Buy Reiterates $72 → $99 | Buy | Reiterates | $72 → $99 | +25.97% | Jul 29, 2026 |
Financial Forecast
Revenue This Year
994.36M
from 677.56M
Increased by 46.76%
Revenue Next Year
1.22B
from 994.36M
Increased by 22.90%
EPS This Year
1.33
from 0.75
Increased by 76.76%
EPS Next Year
1.95
from 1.33
Increased by 47.00%
EPS and Forward PE are based on non-GAAP adjusted numbers.